Perinatal TMS

Prenatal TMS

Research supports TMS as a promising treatment option for depression during pregnancy, particularly for patients seeking to avoid or minimize medication exposure. Clinical trials, including a randomized controlled trial and open-label studies in pregnant women with major depressive disorder, have demonstrated meaningful reductions in depressive symptoms with goodtolerability [1] [2].

Systematic reviews and meta-analyses similarly report significant symptom improvement and reassuring maternal and fetal safety data, with no serious adverse obstetric or neonatal outcomes identified in the availableliterature [3] [4].

While larger studies are ongoing, current evidence suggests that TMS is a viable and well-tolerated non-pharmacologic treatment during pregnancy.

Postpartum TMS

TMS has also shown effectiveness for depression in the postpartum period, where untreated symptoms can significantly affect maternal functioning and infant bonding. Reviews of peripartum populations, including postpartum patients, demonstrate significant reductions in depressive symptoms and favorable tolerabilityprofiles [3] [5].

Importantly, because TMS is not a systemic medication, it does not transfer into breast milk, making it an appealing option for breastfeeding mothers. Emerging literature continues to support TMS as a safe and effective treatment for postpartum depression, expanding access to non-medication-based care during this criticalperiod [4] [5].

TMS for Depression During Pregnancy and Postpartum

If you're experiencing depression during pregnancy or after your baby is born, you're not alone—and you're not without options. TMS offers a non-medication treatment that is both effective and well-tolerated during the perinatal period.

Why Treatment Matters

Depression affects approximately 12% of women during pregnancy and the postpartum period.¹ If you're experiencing depression during this important time, you may wonder whether treatment is truly necessary.

The evidence is clear: untreated depression poses serious risks to both you and your baby. ² ³

Get On The Schedule

Risks of Untreated Perinatal Depression

For Your Baby

Research shows untreated depression during pregnancy and postpartum can affect your child in multiple ways: ² ³

Developmental delays in social, language, motor, and cognitive skills
Attachment difficulties and problems with mother-infant bonding
Behavioral and emotional problems extending into childhood
Increased risk of psychiatric disorders later in life

For You

Untreated depression affects your wellbeing and ability to care for your baby:²

Difficulty bonding with your baby
Reduced engagement in positive parenting behaviors
Higher risk of early cessation of breastfeeding
Persistent depression that can continue for months or years

You don’t have to navigate this alone.

Get On The Schedule

Why TMS for Perinatal Depression

No Medication Exposure

Unlike antidepressants, TMS does not enter your bloodstream, which means zero exposure to your developing baby during pregnancy or to your nursing infant through breast milk. ⁴ ⁵

Proven Effectiveness

Studies show TMS effectively treats perinatal depression, with clinical response rates between 41% and 71%. ⁴ ⁶

Excellent Safety Profile

Multiple studies confirm TMS safety during pregnancy and postpartum: ⁴ ⁵ ⁶ ⁷

No serious adverse events reported in mothers
No obstetric complications or adverse effects on newborn development
Side effects typically mild, such as headache or scalp discomfort
No disruption to breastfeeding

Additional Benefits

TMS may also reduce anxiety symptoms and improve cognitive function, with benefits lasting months after treatment.⁴

Get On The Schedule

TMS vs. Antidepressant Medications

Medication Considerations¹

Some antidepressants are associated with increased risk of birth defects.
Antidepressants may increase risk of preterm birth and neonatal complications.
Medications pass into breast milk.
Medications can cause systemic side effects.

TMS Advantages

No drug exposure to your baby
No risk of medication-related exposure during pregnancy or breastfeeding
Safe while breastfeeding
No systemic side effects

What to Expect

Sessions under 20 minutes
Typically delivered 5 days per week for about 6 weeks, with accelerated options available
You remain awake and alert
You can resume normal activities immediately after
No interruption to breastfeeding

Get On The Schedule

Is TMS Safe During Pregnancy and Postpartum?

Research supports TMS as a safe and well-tolerated treatment during both pregnancy and postpartum, with no serious adverse effects reported for mothers or babies. ⁴ ⁵ ⁶ ⁷

The Bottom Line

Depression during pregnancy and postpartum is not something to endure alone. Untreated depression poses real risks to both you and your baby

TMS offers an effective treatment that addresses your depression while eliminating concerns about medication exposure.

Schedule your consultation today.

Get On The Schedule

New Connections, New Hope

Get On The Schedule

Check back soon

Once posts are published, you’ll see them here.

Sources

Kovich H, Kim W, Quast AM. Pharmacologic Treatment of Depression. American Family Physician.2023;107(2):173-181.
Rogers A, Obst S, Teague SJ, et al. Association Between Maternal Perinatal Depression and Anxiety and Child and Adolescent Development: A Meta-Analysis. JAMA Pediatrics. 2020;174(11):1082-1092.
Netsi E, Pearson RM, Murray L, et al. Association of Persistent and Severe Postnatal Depression With Child Outcomes. JAMA Psychiatry. 2020;75(3):247-253.
Cox EQ, Killenberg S, Frische R, et al. Repetitive Transcranial Magnetic Stimulation for the Treatment of Postpartum Depression. Journal of Affective Disorders. 2020;264:193-200.
Miuli A, Pettorruso M, Stefanelli G, et al. Beyond the Efficacy of Transcranial Magnetic Stimulation in Peripartum Depression: A Systematic Review Exploring Perinatal Safety for Newborns. Psychiatry Research.2023;326:115251.
Liu C, Pan W, Jia L, et al. Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation for Peripartum Depression: A Meta-Analysis of Randomized Controlled Trials. Psychiatry Research. 2020;294:113543.
Ganho-Ávila A, Sobral M, Berg MLD. Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation in Reducing Depressive Symptoms During the Peripartum Period. Current Opinion in Psychiatry.2024;37(5):337-349.